JP3987825B2 - Cosmetics and cosmetic ingredients - Google Patents
Cosmetics and cosmetic ingredients Download PDFInfo
- Publication number
- JP3987825B2 JP3987825B2 JP2003385315A JP2003385315A JP3987825B2 JP 3987825 B2 JP3987825 B2 JP 3987825B2 JP 2003385315 A JP2003385315 A JP 2003385315A JP 2003385315 A JP2003385315 A JP 2003385315A JP 3987825 B2 JP3987825 B2 JP 3987825B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- acid
- skin
- component
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002537 cosmetic Substances 0.000 title claims description 38
- 239000008406 cosmetic ingredient Substances 0.000 title description 4
- 239000000284 extract Substances 0.000 claims description 92
- 239000000203 mixture Substances 0.000 claims description 53
- 238000009472 formulation Methods 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 39
- 241000196324 Embryophyta Species 0.000 claims description 28
- 230000008591 skin barrier function Effects 0.000 claims description 25
- 229910001868 water Inorganic materials 0.000 claims description 24
- 239000002904 solvent Substances 0.000 claims description 16
- 230000009471 action Effects 0.000 claims description 14
- 230000003078 antioxidant effect Effects 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 10
- 241000047339 Salicornia brachystachya Species 0.000 claims description 8
- 150000001298 alcohols Chemical class 0.000 claims description 8
- 239000012046 mixed solvent Substances 0.000 claims description 8
- 241000207965 Acanthaceae Species 0.000 claims description 7
- 238000013329 compounding Methods 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 6
- 150000005846 sugar alcohols Polymers 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 36
- 239000000243 solution Substances 0.000 description 36
- -1 polyoxyethylene Polymers 0.000 description 33
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 27
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 24
- 238000011084 recovery Methods 0.000 description 24
- 238000012360 testing method Methods 0.000 description 24
- 239000000839 emulsion Substances 0.000 description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 18
- 239000000523 sample Substances 0.000 description 18
- 240000007594 Oryza sativa Species 0.000 description 16
- 235000007164 Oryza sativa Nutrition 0.000 description 16
- 238000000605 extraction Methods 0.000 description 16
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 16
- 239000000843 powder Substances 0.000 description 16
- 235000009566 rice Nutrition 0.000 description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 239000003963 antioxidant agent Substances 0.000 description 15
- 235000006708 antioxidants Nutrition 0.000 description 15
- 239000008213 purified water Substances 0.000 description 15
- 235000014113 dietary fatty acids Nutrition 0.000 description 13
- 239000000194 fatty acid Substances 0.000 description 13
- 229930195729 fatty acid Natural products 0.000 description 13
- 229940058015 1,3-butylene glycol Drugs 0.000 description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- 235000019437 butane-1,3-diol Nutrition 0.000 description 12
- 239000006071 cream Substances 0.000 description 12
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 11
- 239000002260 anti-inflammatory agent Substances 0.000 description 10
- 229940121363 anti-inflammatory agent Drugs 0.000 description 10
- 235000011187 glycerol Nutrition 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 10
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000004310 lactic acid Substances 0.000 description 9
- 235000014655 lactic acid Nutrition 0.000 description 9
- 230000003405 preventing effect Effects 0.000 description 9
- 230000009759 skin aging Effects 0.000 description 9
- 230000004888 barrier function Effects 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 8
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 8
- 229960004705 kojic acid Drugs 0.000 description 8
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 8
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 8
- 229960002216 methylparaben Drugs 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 206010015150 Erythema Diseases 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 7
- 229960005070 ascorbic acid Drugs 0.000 description 7
- 231100000321 erythema Toxicity 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 229940057995 liquid paraffin Drugs 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 230000036284 oxygen consumption Effects 0.000 description 7
- 239000002304 perfume Substances 0.000 description 7
- 230000005068 transpiration Effects 0.000 description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 6
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 6
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 5
- 244000267823 Hydrangea macrophylla Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 5
- 239000000419 plant extract Substances 0.000 description 5
- 229940032094 squalane Drugs 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 241001474374 Blennius Species 0.000 description 4
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 4
- 235000019482 Palm oil Nutrition 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 239000002540 palm oil Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 4
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000002211 L-ascorbic acid Substances 0.000 description 3
- 235000000069 L-ascorbic acid Nutrition 0.000 description 3
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000208422 Rhododendron Species 0.000 description 3
- 241000201895 Salicornia Species 0.000 description 3
- 244000062793 Sorghum vulgare Species 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229940069521 aloe extract Drugs 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000000440 bentonite Substances 0.000 description 3
- 229910000278 bentonite Inorganic materials 0.000 description 3
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 229940119217 chamomile extract Drugs 0.000 description 3
- 235000020221 chamomile extract Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 3
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 3
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229940119170 jojoba wax Drugs 0.000 description 3
- 235000019713 millet Nutrition 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 235000019271 petrolatum Nutrition 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 3
- 229960003415 propylparaben Drugs 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 2
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 2
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000004129 EU approved improving agent Substances 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 240000000731 Fagus sylvatica Species 0.000 description 2
- 235000010099 Fagus sylvatica Nutrition 0.000 description 2
- 241001071795 Gentiana Species 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- ACFGRWJEQJVZTM-LEJBHHMKSA-L Magnesium L-ascorbic acid-2-phosphate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1O ACFGRWJEQJVZTM-LEJBHHMKSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 241000201920 Salicornia bigelovii Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 241001247821 Ziziphus Species 0.000 description 2
- 235000001329 Ziziphus joazeiro Nutrition 0.000 description 2
- 244000158786 Ziziphus joazeiro Species 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 229960002298 aminohydroxybutyric acid Drugs 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 229940067596 butylparaben Drugs 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical class O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 2
- 239000008347 soybean phospholipid Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 2
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- QVSVMNXRLWSNGS-UHFFFAOYSA-N (3-fluorophenyl)methanamine Chemical compound NCC1=CC=CC(F)=C1 QVSVMNXRLWSNGS-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LNJRMYPOKFOJBQ-UHFFFAOYSA-N 1-(4-tert-butyl-4-methoxycyclohexa-1,5-dien-1-yl)ethanone Chemical compound COC1(C(C)(C)C)CC=C(C(C)=O)C=C1 LNJRMYPOKFOJBQ-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- ATWGXJGRRXIETI-UHFFFAOYSA-N 2,5-diacetyloxybenzoic acid Chemical compound CC(=O)OC1=CC=C(OC(C)=O)C(C(O)=O)=C1 ATWGXJGRRXIETI-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- GWHXAZLLZVWMNI-UHFFFAOYSA-N 2-acetyloxy-5-hydroxybenzoic acid Chemical compound CC(=O)OC1=CC=C(O)C=C1C(O)=O GWHXAZLLZVWMNI-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- UPHOTCBFZHQJEK-UHFFFAOYSA-N 2-hydroxy-5-propanoyloxybenzoic acid Chemical compound CCC(=O)OC1=CC=C(O)C(C(O)=O)=C1 UPHOTCBFZHQJEK-UHFFFAOYSA-N 0.000 description 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 1
- HWLBIEAKJSRKOD-UHFFFAOYSA-N 2-octadecanoyloxyacetic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)=O HWLBIEAKJSRKOD-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 1
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 description 1
- NYARJMRXCRSQPJ-UHFFFAOYSA-N 4-(3-methylbutyl)benzene-1,3-diol Chemical compound CC(C)CCC1=CC=C(O)C=C1O NYARJMRXCRSQPJ-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- 235000021537 Beetroot Nutrition 0.000 description 1
- CAHQGWAXKLQREW-UHFFFAOYSA-N Benzal chloride Chemical compound ClC(Cl)C1=CC=CC=C1 CAHQGWAXKLQREW-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 241000871189 Chenopodiaceae Species 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241001072282 Limnanthes Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000005308 Pandanus Nutrition 0.000 description 1
- 244000237247 Pandanus dubius Species 0.000 description 1
- 235000012110 Pandanus odorus Nutrition 0.000 description 1
- 244000180021 Pandanus odorus Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 244000015113 Salicornia europaea Species 0.000 description 1
- 235000003042 Salicornia europaea Nutrition 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 241000592344 Spermatophyta Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 1
- GWVPJQDUGPKIOI-UQKRIMTDSA-N [Na].CCCCCCCCCCCC(=O)CN[C@@H](C)C(O)=O Chemical compound [Na].CCCCCCCCCCCC(=O)CN[C@@H](C)C(O)=O GWVPJQDUGPKIOI-UQKRIMTDSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940006091 aloe polysaccharide Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-ZIQFBCGOSA-N alpha-Arbutin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-ZIQFBCGOSA-N 0.000 description 1
- 229940033280 alpha-arbutin Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940093740 amino acid and derivative Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical group C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940105039 coconut extract Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical class [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000013022 formulation composition Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical group CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229940017219 methyl propionate Drugs 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-N methyl undecanoic acid Natural products CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940083256 peripheral vasodilators nicotinic acid and derivative Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- LRUISGPJGHTCRR-LEJBHHMKSA-M sodium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] sulfate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(OS([O-])(=O)=O)=C1O LRUISGPJGHTCRR-LEJBHHMKSA-M 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
Description
本発明は、皮膚角層のバリア機能回復効果とさらには抗酸化作用並びに抗炎症作用を有し、皮膚を健全でみずみずしい状態に維持或いは改善すると共に皮膚の老化防止にも有効な化粧料、並びに化粧料にかかる効果を付与するための化粧料配合剤に関する。 The present invention relates to a cosmetic material that has an effect of restoring the barrier function of the skin stratum corneum, and further has an antioxidant action and an anti-inflammatory action, maintains or improves the skin in a healthy and fresh state, and is effective in preventing skin aging, and The present invention relates to a cosmetic compounding agent for imparting effects on cosmetics.
皮膚最外層の角層は、微生物や有害物質など外界の異物の生体への接触、浸透から生体を保護すると共に、皮膚表面からの水分の蒸散を防いで、皮膚を健全でみずみずしい状態に保持する所謂バリア機能を果たしている。
加齢、過度の水仕事等によりこのバリア機能が低下すると、皮膚表面からの水分蒸散(Transepidermal Water Loss;TEWL)が増加し、角質層の水分量が低下してドライスキン現象を生じ、皮膚はカサカサした肌荒れ状態を呈する。
この皮膚バリア機能の低下を防ぎ、皮膚表面からの水分蒸散、ひいてはドライスキン現象や肌荒れの発生を予防或いは改善するため、従来よりワセリン、スクワラン、エステル油などの閉塞剤を用いて経表皮水分蒸散(TEWL)を抑止する方法、グリセリン、NMF関連成分(ピロリドンカルボン酸ナトリウム、乳酸ナトリウム等)、加水分解コラーゲン、コラーゲン誘導体などの保湿成分を皮膚に補給し、皮膚の水分保持能を高める方法、胎盤抽出物、ビタミン類などの細胞賦活成分を用いて表皮細胞の角質化を促進する方法等が提案されているが、それら従来の方法の場合には、効果が一時的であるとか、或いは有効性が必ずしも十分でなく満足すべき効果を得るため配合量を増やすと皮膚適用時にべとつき等を生じて使用感が低下したり、安全性の面で問題の生ずることがあるなどの難点があった。
The stratum corneum, the outermost skin layer, protects the living body from contact and penetration of foreign matter such as microorganisms and harmful substances, and prevents the evaporation of moisture from the skin surface to keep the skin healthy and fresh. It performs a so-called barrier function.
When this barrier function is reduced due to aging, excessive water work, etc., the water evaporation from the skin surface (Transepidermal Water Loss; TEWL) increases, the water content of the stratum corneum decreases and the dry skin phenomenon occurs. Exhibits rough skin.
In order to prevent this skin barrier function from decreasing and to prevent or improve moisture transpiration from the skin surface, and thus dry skin and rough skin, transepidermal moisture transpiration has been conventionally used using occlusive agents such as petroleum jelly, squalane and ester oil. (TEWL) deterrent method, glycerin, NMF-related components (sodium pyrrolidonecarboxylate, sodium lactate, etc.), hydrolyzed collagen, collagen derivatives, and other moisturizing ingredients are added to the skin to enhance the water retention capacity of the skin, placenta Methods for promoting keratinization of epidermal cells using cell activation components such as extracts and vitamins have been proposed, but in the case of these conventional methods, the effect is temporary or effective. However, if the amount is increased to obtain a satisfactory effect, it may cause stickiness when applied to the skin, resulting in a decreased feeling of use or safety. There is a drawback such as may occur with in the surface problem.
本発明者等は、皮膚バリア機能を回復し、皮膚を健全でみずみずしくハリのある状態に保持、改善せしめるための方法並びに剤にみられる上記の如き問題点に鑑み、有効性と安全性の両面を満足すると共に、使用感等にもすぐれた新たな皮膚バリア機能回復剤、並びにかかる剤を含有し肌荒れの予防、症状改善に有効でかつ高い生体安全性と良好な使用感、使用後感を具えた化粧料を提供すべく鋭意研究を進めた結果、アカザ科(Chenopodiaceae)に属する種子植物であるアッケシソウ属植物の抽出物がすぐれた皮膚バリア機能回復作用を有し、皮膚からの水分蒸散の防止或いは皮膚水分保持能の改善に顕著な効果を示すと共に、天然物由来であるが故に生体に対する安全性も高く又使用感も良好であって、上記の目的に合致するものであることを見出すに至った。 In view of the above-mentioned problems in the method and agent for recovering the skin barrier function and maintaining and improving the skin in a healthy, fresh and firm state, both the effectiveness and safety are considered. A new skin barrier function recovery agent with excellent usability and the like, as well as prevention of rough skin, effective improvement of symptoms, high biological safety, good usability, and feeling after use. As a result of diligent research to provide the prepared cosmetics, the extract of the plant belonging to the genus Acanthaceae, which is a seed plant belonging to Chenopodiaceae, has an excellent skin barrier function recovery action, and the moisture transpiration from the skin It has a remarkable effect on prevention or improvement of skin moisture retention ability, and since it is derived from a natural product, it is highly safe for the living body and has a good feeling of use and meets the above purpose. It led to the issue.
そればかりでなく、本発明者等のさらなる検討の結果、アカザ科アッケシソウ属の植物の抽出物が、皮膚バリア機能回復作用に加えて、抗酸化作用とシクロオキシゲナーゼ活性抑制作用に基づく抗炎症作用をも併せ持つことが明らかとなった。
従って、アカザ科アッケシソウ属の植物の抽出物を配合した化粧料によれば、該抽出物の有する皮膚バリア機能回復作用に基づいて、皮膚からの水分蒸散が防止され或いは皮膚水分保持能が改善されることにより、肌荒れの予防或いは症状改善が可能となるだけでなく、紫外線やストレスなどで発生するラジカルの消去と炎症の抑制により皮膚の老化を抑止或いは改善し、肌を若々しい状態に保持、回復するという皮膚老化防止効果をも奏せしめることができる。
In addition, as a result of further studies by the present inventors, the extract of the plant belonging to the genus Acanthaceae also has an anti-inflammatory action based on an antioxidant action and a cyclooxygenase activity-inhibiting action in addition to an action to restore the skin barrier function. It became clear to have both.
Therefore, according to the cosmetic containing the extract of the plant belonging to the genus Rhizoaceae, the transpiration of moisture from the skin is prevented or the ability to retain the moisture of the skin is improved based on the skin barrier function recovery action of the extract. In addition to preventing rough skin and improving symptoms, it also prevents or improves skin aging by eliminating radicals generated by ultraviolet rays and stress and suppressing inflammation, keeping the skin youthful In addition, the skin aging preventing effect of recovery can be exhibited.
即ち、本発明は第一に、アカザ科アッケシソウ属の植物を、水又は水と親水性溶媒との混合溶媒で抽出して得られる抽出物を有効成分としてなり、皮膚バリア機能回復作用、抗酸化作用及び抗炎症作用を併せ持つ化粧料配合剤に関するものである。
本発明は第二に、上記の化粧料用配合剤を配合したことを特徴とする化粧料に関するものである。
なお、本明細書に於いて化粧料とは、所謂化粧料のほかに医薬部外品をも含む意味で用いる。
That is, the present invention firstly uses, as an active ingredient, an extract obtained by extracting a plant belonging to the genus Rhizoaceae with water or a mixed solvent of water and a hydrophilic solvent, and restores skin barrier function, antioxidants. The present invention relates to a cosmetic compounding agent having both an action and an anti-inflammatory action .
Secondly, the present invention relates to a cosmetic comprising the above-described cosmetic compounding agent .
In the present specification, cosmetics are used in the sense of including quasi-drugs in addition to so-called cosmetics.
上記第一の構成からなる本発明の化粧料配合剤は、有効成分たるアカザ科アッケシソウ属植物の溶媒抽出物の奏するすぐれた皮膚バリア機能回復作用、抗酸化作用並びに抗炎症作用に基づき、肌荒れの予防或いは症状改善に有効でさらに皮膚老化防止効果をも有する化粧料を与えると共に、皮膚刺激等が少なく安全性にすぐれ、かつべとつき感がなく皮膚とのなじみが良好との特性を具えることから、これを配合してなる化粧料は、生体安全性並びに使用感の点で満足すべきものとなる。
又、上記第二の構成からなる本発明の化粧料は、これを皮膚に適用したとき、有効成分として含む上記化粧料配合剤のすぐれた皮膚バリア機能回復作用に基づき、皮膚表面からの水分蒸散を防ぎ或いは皮膚水分保持能を改善して肌荒れを予防或いは改善し、皮膚を健全でみずみずしくハリのある状態に回復するばかりでなく、該配合剤が併せ奏する抗酸化作用及び抗炎症作用が、皮膚老化の要因となるラジカルの消去や炎症の抑制に働く結果、皮膚の老化が防止され肌は若々しい状態に保持される。
The cosmetic ingredient of the present invention comprising the above first configuration, the serving active ingredient Chenopodiaceae Salicornia plants of the genus excellent skin barrier function recovery effect achieved by the solvent extract, based on the antioxidant and anti-inflammatory action, rough skin Because it provides cosmetics that are effective for prevention or symptom improvement and also has an anti-skin aging effect, has low skin irritation, etc., is safe, has no stickiness, and has good characteristics with the skin. A cosmetic comprising this is satisfactory in terms of biosafety and feeling of use .
In addition, the cosmetic composition of the present invention having the above-mentioned second configuration is capable of transpiration of moisture from the skin surface when applied to the skin, based on the excellent skin barrier function recovery action of the cosmetic formulation composition containing as an active ingredient. Prevent or improve rough skin by preventing or improving skin moisture retention, not only to restore the skin to a healthy, fresh and firm state, but also the antioxidant and anti-inflammatory effects combined with the combination As a result of eliminating radicals that cause aging and suppressing inflammation, skin aging is prevented and the skin is kept in a youthful state.
以下、本発明について詳細に説明する。
本発明の抽出物の調製に用いるアカザ科アッケシソウ属の植物としては、例えばアッケシソウ(Salicornia herbacea)、サリコルニア・ユーロパエア(Salicornia europaea)、サリコルニア・ビゲロヴィ(Salicornia bigelovii)、サリコルニア・ドリコスタキア・エスエスピー・ストリクティシマ(Salicornian dolichostachya ssp strictissima)などが挙げられる。
それらのうちでも、得られる抽出物の皮膚バリア機能回復作用などの作用効果の観点、さらには原料入手の容易さ等の点からアッケシソウ(Salicornia herbacea)の使用が最も好ましい。
Hereinafter, the present invention will be described in detail.
Examples of the plant belonging to the genus Acanthaceae used in the preparation of the extract of the present invention include, for example, Salicornia herbacea, Salicornia europaea, Salicornia bigelovii, Salicornia dricostacia sp. Shima (Salicornian dolichostachya ssp strictissima).
Among them, the use of hammocha (Salicornia herbacea) is most preferable from the viewpoints of the action and effect such as the skin barrier function recovery action of the extract obtained, and the availability of raw materials.
それらアカザ科アッケシソウ属植物の抽出物を調製する場合、該植物の抽出部位には特に限定はなく、例えば種子、葉、茎、根、全草など適宜の部分を用いることができるが、なかでも茎又は全草が最も好ましい。抽出物の調製は、アッケシソウ属植物の抽出しようとする部位を必要ならば予め水洗して異物を除いた後、そのままもしくは乾燥した上、必要に応じて細切或いは粉砕し、浸漬法、向流抽出法など常法に従って抽出溶媒と接触せしめることによって行うことができる。 In the case of preparing an extract of these genus Acanthaceae plants, there are no particular limitations on the extraction site of the plant, and for example, appropriate parts such as seeds, leaves, stems, roots, whole grasses can be used. Most preferred are stems or whole plants. The extract should be prepared by washing the part of the plant belonging to the genus Rhododendron in advance with water if necessary to remove foreign substances, and then directly or after drying, chopping or grinding as necessary, soaking method, countercurrent It can carry out by making it contact with an extraction solvent in accordance with conventional methods, such as an extraction method.
抽出溶媒としては、水;メタノール、エタノール、プロパノールなどの低級アルコール類、オレイルアルコール、ステアリルアルコール、オクチルドデカノールなどの高級アルコール類;エチレングリコール、プロピレングリコール、1,3−ブチレングリコール、グリセリンなどの多価アルコール類;酢酸エチル、酢酸ブチル、プロピオン酸メチル、トリオクタン酸グリセリルなどのエステル類;アセトン、メチルエチルケトンなどのケトン類;エチルエーテル、イソプロピルエーテルなどのエーテル類;n−ヘキサン、トルエン、クロロホルムなどの炭化水素系溶媒などが挙げられ、それらは単独でもしくは二種以上混合して用いられる。 As an extraction solvent, water; lower alcohols such as methanol, ethanol, and propanol; higher alcohols such as oleyl alcohol, stearyl alcohol, and octyldodecanol; many solvents such as ethylene glycol, propylene glycol, 1,3-butylene glycol, and glycerin Monohydric alcohols; esters such as ethyl acetate, butyl acetate, methyl propionate and glyceryl trioctanoate; ketones such as acetone and methyl ethyl ketone; ethers such as ethyl ether and isopropyl ether; carbonization such as n-hexane, toluene and chloroform Examples thereof include hydrogen-based solvents, which are used alone or in combination of two or more.
それら抽出溶媒のうちでも、得られる抽出物の皮膚バリア機能回復作用等の観点から、また化粧料への幅広い適用が可能であるという点からも、本発明に於いては水、低級アルコール類或いは多価アルコール類などの親水性溶媒が好適に用いられる。この親水性溶媒を用いる場合の好ましい例としては、例えば水もしくは低級アルコール類(特にエタノール)の単独使用、或いは水と低級アルコール類(特にエタノール)との混合溶媒又は水と多価アルコール類(特に1,3−ブチレングリコールもしくはプロピレングリコール)との混合溶媒の使用等が挙げられるが、なかでも水の単独使用が最も好ましい。 Among these extraction solvents, water, lower alcohols or the like in the present invention from the viewpoint of the skin barrier function recovery action and the like of the extract obtained, and also from the viewpoint that it can be widely applied to cosmetics. A hydrophilic solvent such as a polyhydric alcohol is preferably used. Preferred examples of using this hydrophilic solvent include, for example, water or lower alcohols (especially ethanol) used alone, or a mixed solvent of water and lower alcohols (especially ethanol) or water and polyhydric alcohols (especially Use of a mixed solvent with 1,3-butylene glycol or propylene glycol) is exemplified, and water alone is most preferable.
混合溶媒を用いる場合、各溶媒の混合比は、例えば水とエタノールとの混合溶媒であれば、重量比(以下同じ)で1:5〜25:1、水と1,3−ブチレングリコールとの混合溶媒であれば1:5〜15:1、又水とプロピレングリコールとの混合溶媒であれば、1:5〜15:1の範囲とすることが好ましい。 In the case of using a mixed solvent, the mixing ratio of each solvent is, for example, 1: 5 to 25: 1 by weight ratio (hereinafter the same) if water and ethanol are mixed solvent, and water and 1,3-butylene glycol. In the case of a mixed solvent, it is preferably in the range of 1: 5 to 15: 1, and in the case of a mixed solvent of water and propylene glycol, it is preferably in the range of 1: 5 to 15: 1.
抽出物の調製に際して、抽出液のpHに特に限定はないが一般には4〜8の範囲とすることが好ましく、かかる意味で、必要ならば上記の抽出溶媒に、水酸化ナトリウム、炭酸ナトリウム、水酸化カリウムなどのアルカリ性調整剤や、クエン酸、塩酸、リン酸、硫酸などの酸性調整剤等を配合し、所望のpHとなるように調整してもよい。 In the preparation of the extract, the pH of the extract is not particularly limited, but is generally preferably in the range of 4 to 8. In this sense, if necessary, the above extraction solvent may be sodium hydroxide, sodium carbonate, water. You may mix | blend alkaline adjusters, such as potassium oxide, acidic adjusters, such as a citric acid, hydrochloric acid, phosphoric acid, and a sulfuric acid, and you may adjust so that it may become desired pH.
浴比、抽出温度、抽出時間等の抽出条件は、用いる溶媒の種類やpH、或いは植物の抽出部位・細切度等によっても異なるが、例えば水を抽出溶媒とする浸漬法の場合であれば、浴比は重量比で、植物体に対して溶媒が1〜50倍量、好ましくは1〜20倍量の範囲であり、抽出温度は、一般に4〜100℃、好ましくは4〜80℃の範囲である。又抽出時間は、4℃の冷温抽出の場合で8時間〜50日間、特に24時間〜20日間、40℃の中温抽出の場合で4時間〜20日間、特に8時間〜5日間、80℃の高温抽出の場合で10分〜8時間、特に30分〜3時間とするのがよい。 Extraction conditions such as bath ratio, extraction temperature, and extraction time vary depending on the type and pH of the solvent used, or the extraction site and shredding degree of the plant, but for example, in the case of the immersion method using water as the extraction solvent The bath ratio is a weight ratio, and the solvent is in the range of 1 to 50 times, preferably 1 to 20 times the amount of the plant, and the extraction temperature is generally 4 to 100 ° C, preferably 4 to 80 ° C. It is a range. The extraction time is 8 hours to 50 days in the case of cold extraction at 4 ° C., particularly 24 hours to 20 days, 4 hours to 20 days in the case of medium temperature extraction at 40 ° C., particularly 8 hours to 5 days, 80 ° C. In the case of high temperature extraction, the time is preferably 10 minutes to 8 hours, particularly 30 minutes to 3 hours.
かくして得られる抽出物溶液は、一般にはpHを4〜8に調整した上、これをそのまま化粧料配合剤として使用してもよく、又必要ならば減圧濃縮等により適宜の濃度として用いてもよい。さらに場合によっては、スプレードライ法、凍結乾燥法など常法に従って粉末化することもできる。
なお、アッケシソウ属植物に含まれる油成分、例えばサリコルニア・ビゲロヴィの種子から得られるオイルも化粧品配合原料として有用である。
The extract solution thus obtained is generally adjusted to a pH of 4 to 8, and may be used as it is as a cosmetic compounding agent, or may be used at an appropriate concentration by vacuum concentration or the like if necessary. . Further, depending on the case, it can be pulverized according to a conventional method such as spray drying or freeze drying.
In addition, oil components contained in plants belonging to the genus Hydrangea, such as oil obtained from the seeds of Saricornia bigerovi, are also useful as cosmetic ingredients.
以上の如くして調製される本発明のアカザ科アッケシソウ属植物の抽出物は、後に試験例1〜4に示す通り、皮膚バリア機能を正常な状態に回復して表皮からの水分蒸散を抑制する作用と、さらに抗酸化作用及びシクロオキシゲナーゼ活性抑制作用に基づく抗炎症作用を有し、しかも生体安全性、皮膚適用時の使用感にもすぐれ、肌荒れの予防、改善や皮膚の老化防止を目的として化粧料に配合して極めて有用なものである。従って、本発明によればかかるアカザ科アッケシソウ属植物の抽出物を有効成分としてなり、皮膚バリア機能回復作用、抗酸化作用及び抗炎症作用を併せ持つ化粧料配合剤(皮膚バリア機能回復・抗酸化・抗炎症剤)並びに該配合剤を含有する化粧料が提供される。 As described later in Test Examples 1 to 4, the extract of the genus Acanthaceae of the present invention prepared as described above recovers the skin barrier function to a normal state and suppresses moisture transpiration from the epidermis. It has anti-inflammatory action based on anti-oxidation action and cyclooxygenase activity suppression action, and also has excellent biological safety, a feeling of use at the time of skin application, makeup for the purpose of preventing rough skin, improving and preventing skin aging It is extremely useful when blended into the material. Accordingly, as an active ingredient an extract of Chenopodiaceae Salicornia genus plant according According to the present invention, the skin barrier function recovery effect, antioxidant and anti-inflammatory combines the effects cosmetic ingredient (skin barrier function recovery and antioxidants, Anti-inflammatory agents) and cosmetics containing the combination are provided.
本発明のアカザ科アッケシソウ属植物の抽出物を含む化粧料としては、例えば乳液、クリーム、ローション、エッセンス、パックなどの基礎化粧料、口紅、ファンデーション、リクイドファンデーション、メイクアッププレスパウダー、ほほ紅、白粉などのメイクアップ化粧料、洗顔料、ボディーシャンプー、石けんなどの清浄用化粧料、さらには浴剤等が挙げられるが、勿論これらに限定されるものではない。 Examples of cosmetics containing the extract of the genus Acanthaceae of the present invention include basic cosmetics such as emulsions, creams, lotions, essences, packs, lipsticks, foundations, liquid foundations, makeup press powders, blushers, white powders. Makeup cosmetics such as facial cleansers, body shampoos, soaps and other cleaning cosmetics, and bath agents, but of course are not limited thereto.
本発明の化粧料に於けるアカザ科アッケシソウ属植物抽出物の配合量は、抽出物の固形分として、基礎化粧料の場合は、一般に0.001〜5重量%、好ましくは0.01〜2重量%の範囲、メイクアップ化粧料の場合は、一般に0.001〜3重量%、好ましくは0.01〜1重量%の範囲、又清浄用化粧料の場合は、一般に0.001〜5重量%、好ましくは0.01〜2重量%の範囲である。 In the cosmetic composition of the present invention, the amount of the extract of the plant belonging to the genus Rhizoaceae is generally 0.001 to 5% by weight, preferably 0.01 to 2% as the solid content of the extract in the case of basic cosmetics. In the range of% by weight, in the case of makeup cosmetics, generally 0.001 to 3% by weight, preferably in the range of 0.01 to 1% by weight, and in the case of cleansing cosmetics, generally 0.001 to 5% by weight. %, Preferably in the range of 0.01 to 2% by weight.
本発明の化粧料には、必須成分のアカザ科アッケシ属植物抽出物のほかに、通常化粧料に用いられる成分、例えば油性成分、界面活性剤(合成系、天然物系)、保湿剤、増粘剤、防腐・殺菌剤、粉体成分、紫外線吸収剤、色素、香料、生理活性成分等を必要に応じて適宜配合することができる。 The cosmetics of the present invention include components that are usually used in cosmetics, for example, oily components, surfactants (synthetic systems, natural products), moisturizers, potentiators, in addition to the essential components of the plant extract of the genus Akazaceae. A sticking agent, antiseptic / bactericidal agent, powder component, ultraviolet absorber, pigment, fragrance, physiologically active component and the like can be appropriately blended as necessary.
ここで、油性成分としては、例えばオリーブ油、ホホバ油、ヒマシ油、大豆油、米油、米胚芽油、ヤシ油、パーム油、カカオ油、メドウフォーム油、シアーバター、ティーツリー油、アボガド油、マカデミアナッツ油、植物由来スクワランなどの植物由来の油脂類;ミンク油、タートル油などの動物由来の油脂類;ミツロウ、カルナウバロウ、ライスワックス、ラノリンなどのロウ類;流動パラフィン、ワセリン、パラフィンワックス、スクワランなどの炭化水素類;ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、イソステアリン酸、cis−11−エイコセン酸などの脂肪酸類;ラウリルアルコール、セタノール、ステアリルアルコールなどの高級アルコール類;ミリスチン酸イソプロピル、パルミチン酸イソプロピル、オレイン酸ブチル、2−エチルヘキシルグリセライド、高級脂肪酸オクチルドデシル(ステアリン酸オクチルドデシル等)などの合成エステル類及び合成トリグリセライド類等が挙げられる。 Here, as the oil component, for example, olive oil, jojoba oil, castor oil, soybean oil, rice oil, rice germ oil, palm oil, palm oil, cacao oil, meadow foam oil, sheer butter, tea tree oil, avocado oil, Oils derived from plants such as macadamia nut oil and plant-derived squalane; Fats derived from animals such as mink oil and turtle oil; waxes such as beeswax, carnauba wax, rice wax, lanolin; liquid paraffin, petrolatum, paraffin wax, squalane, etc. Hydrocarbons; fatty acids such as myristic acid, palmitic acid, stearic acid, oleic acid, isostearic acid, cis-11-eicosenoic acid; higher alcohols such as lauryl alcohol, cetanol, stearyl alcohol; isopropyl myristate, palmitic acid Isopropyl, me Butyl phosphate, 2-ethylhexyl glycerides, higher fatty acid octyldodecyl (octyl stearate dodecyl and the like), and the synthetic esters and synthetic triglycerides such like.
界面活性剤としては,例えばポリオキシエチレンアルキルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビトール脂肪酸エステルなどの非イオン界面活性剤;脂肪酸塩、アルキル硫酸塩、アルキルベンゼンスルホン酸塩、ポリオキシエチレンアルキルエーテル硫酸塩、ポリオキシエチレン脂肪アミン硫酸塩、ポリオキシエチレンアルキルフェニルエーテル硫酸塩、ポリオキシエチレンアルキルエーテル燐酸塩、α−スルホン化脂肪酸アルキルエステル塩、ポリオキシエチレンアルキルフェニルエーテル燐酸塩などのアニオン界面活性剤;第四級アンモニウム塩、第一級〜第三級脂肪アミン塩、トリアルキルベンジルアンモニウム塩、アルキルピリジニウム塩、2−アルキル−1−アルキル−1−ヒドロキシエチルイミダゾリニウム塩、N,N−ジアルキルモルフォルニウム塩、ポリエチレンポリアミン脂肪酸アミド塩などのカチオン界面活性剤;N,N−ジメチル−N−アルキル−N−カルボキシメチルアンモニオベタイン、N,N,N−トリアルキル−N−アルキレンアンモニオカルボキシベタイン、N−アシルアミドプロピル−N′,N′−ジメチル−N′−β−ヒドロキシプロピルアンモニオスルホベタインなどの両性界面活性剤等を使用することができる。
又、乳化剤乃至乳化助剤として、酵素処理ステビアなどのステビア誘導体、レシチン及びその誘導体、乳酸菌醗酵米、乳酸菌醗酵発芽米、乳酸菌醗酵穀類(麦類、豆類、雑穀など)、ジュアゼイロ(Rhamnaceae zizyphus joazeiro)抽出物等を配合することもできる。
Examples of the surfactant include polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene hydrogenated castor oil, polyoxyethylene Nonionic surfactants such as oxyethylene sorbitol fatty acid esters; fatty acid salts, alkyl sulfates, alkylbenzene sulfonates, polyoxyethylene alkyl ether sulfates, polyoxyethylene fatty amine sulfates, polyoxyethylene alkyl phenyl ether sulfates, Polyoxyethylene alkyl ether phosphates, α-sulfonated fatty acid alkyl ester salts, polyoxyethylene alkyl phenyl ether phosphates, Quaternary ammonium salt, primary to tertiary fatty amine salt, trialkylbenzylammonium salt, alkylpyridinium salt, 2-alkyl-1-alkyl-1-hydroxyethylimidazolinium salt, N N, N-dimethyl-N-alkyl-N-carboxymethylammoniobetaine, N, N, N-trialkyl-N-, N, N-dimethyl-N-alkyl-N-carboxymethylammoniobetaine Amphoteric surfactants such as alkylene ammoniocarboxybetaine and N-acylamidopropyl-N ′, N′-dimethyl-N′-β-hydroxypropylammoniosulfobetaine can be used.
In addition, as emulsifiers or emulsifiers, stevia derivatives such as enzyme-treated stevia, lecithin and its derivatives, lactic acid bacteria fermented rice, lactic acid bacteria fermented rice, lactic acid bacteria fermented cereals (wheat, legumes, millet, etc.), juteiro (Rhamnaceae zizyphus joazeiro) An extract or the like can also be blended.
保湿剤としては、例えばグリセリン、プロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール、ポリエチレングリコール、ソルビトール、キシリトール、ピロリドンカルボン酸ナトリウム等があり、さらにトレハロース等の糖類、乳酸菌醗酵米、ムコ多糖類(例えば、ヒアルロン酸及びその誘導体、コンドロイチン及びその誘導体、ヘパリン及びその誘導体など)、エラスチン及びその誘導体、コラーゲン及びその誘導体、NMF関連物質、乳酸、尿素、高級脂肪酸オクチルドデシル、海藻抽出物、ビャッキュウ抽出物、魚介類由来コラーゲン及びその誘導体、各種アミノ酸及びそれらの誘導体が挙げられる。 Examples of humectants include glycerin, propylene glycol, dipropylene glycol, 1,3-butylene glycol, polyethylene glycol, sorbitol, xylitol, sodium pyrrolidonecarboxylate, and sugars such as trehalose, lactic acid bacteria fermented rice, and mucopolysaccharides. (For example, hyaluronic acid and its derivatives, chondroitin and its derivatives, heparin and its derivatives, etc.), elastin and its derivatives, collagen and its derivatives, NMF related substances, lactic acid, urea, higher fatty acid octyldodecyl, seaweed extract, beech extract Products, seafood-derived collagen and derivatives thereof, various amino acids and derivatives thereof.
増粘剤としては、例えばアルギン酸、寒天、カラギーナン、フコイダン等の褐藻、緑藻或いは紅藻由来成分、ビャッキュウ抽出物、ペクチン、ローカストビーンガム、アロエ多糖体等の多糖類、キサンタンガム、トラガントガム、グアーガム等のガム類、カルボキシメチルセルロース、ヒドロキシエチルセルロース等のセルロース誘導体、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、アクリル酸・メタクリル酸共重合体等の合成高分子類;ヒアルロン酸及びその誘導体、ポリグルタミン酸及びその誘導体等が挙げられる。 Examples of thickeners include, for example, brown algae such as alginic acid, agar, carrageenan, fucoidan, green algae or red algae-derived components, extract of sand cucumber, pectin, locust bean gum, polysaccharides such as aloe polysaccharide, xanthan gum, tragacanth gum, guar gum, etc. Synthetic polymers such as gums, cellulose derivatives such as carboxymethylcellulose, hydroxyethylcellulose, polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinyl polymer, acrylic acid / methacrylic acid copolymer; hyaluronic acid and its derivatives, polyglutamic acid and its derivatives, etc. Is mentioned.
防腐・殺菌剤としては、例えば尿素;パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸ブチルなどのパラオキシ安息香酸エステル類;フェノキシエタノール、ジクロロフェン、ヘキサクロロフェン、塩酸クロルヘキシジン、塩化ベンザルコニウム、サリチル酸、エタノール、ウンデシレン酸、フェノール類、ジャマール(イミダゾデイニールウレア)、1,2−ペンタンジオール、各種精油類、樹皮乾留物等がある。 Examples of the antiseptic / bactericidal agent include urea; paraoxybenzoates such as methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, and butyl paraoxybenzoate; phenoxyethanol, dichlorophene, hexachlorophene, chlorhexidine hydrochloride, benzal chloride Luconium, salicylic acid, ethanol, undecylenic acid, phenols, jamal (imidazodenyl urea), 1,2-pentanediol, various essential oils, bark dry matter, and the like.
粉体成分としては、例えばセリサイト、酸化チタン、タルク、カオリン、ベントナイト、酸化亜鉛、炭酸マグネシウム、酸化マグネシウム、酸化ジルコニウム、硫酸バリウム、無水ケイ酸、雲母、ナイロンパウダー、ポリエチレンパウダー、シルクパウダー、セルロース系パウダー、穀類(米、麦、トウモロコシ、キビなど)のパウダー、豆類(大豆、小豆など)のパウダー等がある。 Examples of powder components include sericite, titanium oxide, talc, kaolin, bentonite, zinc oxide, magnesium carbonate, magnesium oxide, zirconium oxide, barium sulfate, silicic anhydride, mica, nylon powder, polyethylene powder, silk powder, and cellulose. System powders, powders of cereals (rice, wheat, corn, millet, etc.), powders of beans (soybeans, red beans, etc.).
紫外線吸収剤としては、例えばパラアミノ安息香酸エチル、パラジメチルアミノ安息香酸エチルヘキシル、サリチル酸アミル及びその誘導体、パラメトキシ桂皮酸2−エチルヘキシル、桂皮酸オクチル、オキシベンゾン、2,4−ジヒドロキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸塩、4−ターシャリーブチル−4−メトキシベンゾイルメタン、2−(2−ヒドロキシ−5−メチルフェニル)ベンゾトリアゾール、ウロカニン酸、ウロカニン酸エチル、アロエ抽出物等がある。 Examples of the ultraviolet absorber include ethyl paraaminobenzoate, ethylhexyl paradimethylaminobenzoate, amyl salicylate and derivatives thereof, 2-ethylhexyl paramethoxycinnamate, octyl cinnamate, oxybenzone, 2,4-dihydroxybenzophenone, 2-hydroxy-4 -Methoxybenzophenone-5-sulfonate, 4-tertiarybutyl-4-methoxybenzoylmethane, 2- (2-hydroxy-5-methylphenyl) benzotriazole, urocanic acid, ethyl urocanate, aloe extract, etc. .
生理活性成分としては、例えば美白成分として、t−シクロアミノ酸誘導体、コウジ酸及びその誘導体、アスコルビン酸及びその誘導体、ハイドロキノン誘導体、エラグ酸及びその誘導体、レゾルシノール誘導体、ソウハクヒ抽出物、ユキノシタ抽出物、米糠抽出物、米糠抽出物加水分解物、乳酸菌醗酵米、乳酸菌醗酵発芽米、乳酸菌醗酵穀類(麦類、豆類、雑穀類)、白芥子加水分解抽出物、ムラサキシキブ抽出物、パンダヌス・アマリリフォリウス(Pandanus amaryllifolius Roxb.)抽出物、アルカンジェリシア・フラバ(Arcangelicia flava Merrilli)抽出物、カミツレ抽出物(商品名:カモミラET)、コンブ等の海藻の抽出物、アマモ等の海草の抽出物、リノール酸及びその誘導体もしくは加工物(例えばリポソーム化リノール酸など)、2,5−ジヒドロキシ安息香酸誘導体等が挙げられる。 Examples of physiologically active ingredients include whitening ingredients such as t-cycloamino acid derivatives, kojic acid and derivatives thereof, ascorbic acid and derivatives thereof, hydroquinone derivatives, ellagic acid and derivatives thereof, resorcinol derivatives, sucha akuhi extract, yukinoshita extract, rice bran Extract, rice bran extract hydrolyzate, lactic acid bacteria fermented rice, lactic acid bacteria fermented germinated rice, lactic acid bacteria fermented cereals (barley, beans, millet), white coconut hydrolyzed extract, murasakixikibu extract, Pandanus amaririfolios (Pandanus amaryllifolius Roxb.) extract, Arcangelicia flava Merrilli extract, chamomile extract (trade name: chamomile ET), seaweed extract such as kombu, seaweed extract such as sea bream, linoleic acid and Derivatives or processed products thereof (eg liposomal linoleic acid), 2,5-dihydro And xylbenzoic acid derivatives.
上記のコウジ酸誘導体としては、例えばコウジ酸モノブチレート、コウジ酸モノカプレート、コウジ酸モノパルミテート、コウジ酸ジブチレートなどのコウジ酸エステル類、コウジ酸エーテル類、コウジ酸グルコシドなどのコウジ酸糖誘導体等が、アスコルビン酸誘導体としては、例えばL−アスコルビン酸−2−リン酸エステルナトリウム、L−アスコルビン酸−2−リン酸エステルマグネシウム、L−アスコルビン酸−2−硫酸エステルナトリウム、L−アスコルビン酸−2−硫酸エステルマグネシウムなどのアスコルビン酸エステル塩類、L−アスコルビン酸−2−グルコシド(2−O−α−D−グルコピラノシル−L−アスコルビン酸)、L−アスコルビン酸−5−グルコシド(5−O−α−D−グルコピラノシル−L−アスコルビン酸)などのアスコルビン酸糖誘導体、それらアスコルビン酸糖誘導体の6位アシル化物(アシル基は、ヘキサノイル基、オクタノイル基、デカノイル基など)、L−アスコルビン酸テトライソパルミチン酸エステル、L−アスコルビン酸テトララウリン酸エステルなどのL−アスコルビン酸テトラ脂肪酸エステル類、3−O−エチルアスコルビン酸、L−アスコルビン酸−2−リン酸−6−O−パルミテートナトリウム等が、ハイドロキノン誘導体としては、アルブチン(ハイドロキノン−β−D−グルコピラノシド)、α−アルブチン(ハイドロキノン−α−D−グルコピラノシド)等が、レゾルシノール誘導体としては、例えば4−n−ブチルレゾルシノール、4−イソアミルレゾルシノール等が、2,5−ジヒドロキシ安息香酸誘導体としては、例えば2,5−ジアセトキシ安息香酸、2−アセトキシ−5−ヒドロキシ安息香酸、2−ヒドロキシ−5−プロピオニルオキシ安息香酸等が、ニコチン酸誘導体としては、例えばニコチン酸アミド、ニコチン酸ベンジル等が、ビタミンE誘導体としては、例えばビタミンEニコチネート、ビタミンEリノレート等が、α−ヒドロキシ酸としては、例えば乳酸、リンゴ酸、コハク酸、クエン酸、α−ヒドロキシオクタン酸等がある。 Examples of the kojic acid derivatives include kojic acid esters such as kojic acid monobutyrate, kojic acid monocaprate, kojic acid monopalmitate, kojic acid dibutyrate, kojic acid ethers, kojic acid sugar derivatives such as kojic acid glucoside, etc. However, as the ascorbic acid derivatives, for example, L-ascorbic acid-2-phosphate sodium, L-ascorbic acid-2-phosphate magnesium, L-ascorbic acid-2-sulfate sodium, L-ascorbic acid-2 -Ascorbic acid ester salts such as magnesium sulfate, L-ascorbic acid-2-glucoside (2-O-α-D-glucopyranosyl-L-ascorbic acid), L-ascorbic acid-5-glucoside (5-O-α) -D-glucopyranosyl-L-ascorbine Acid) ascorbic acid sugar derivatives, acylated 6-positions of these ascorbic acid sugar derivatives (acyl groups are hexanoyl, octanoyl, decanoyl, etc.), L-ascorbic acid tetraisopalmitate, L-ascorbic acid tetra L-ascorbic acid tetrafatty acid esters such as lauric acid ester, 3-O-ethylascorbic acid, L-ascorbic acid-2-phosphate-6-O-palmitate sodium and the like are hydroquinone derivatives such as arbutin (hydroquinone). -Β-D-glucopyranoside), α-arbutin (hydroquinone-α-D-glucopyranoside) and the like, and as resorcinol derivatives, for example, 4-n-butylresorcinol, 4-isoamylresorcinol and the like are 2,5-dihydroxybenzoic acid. Derivatives and For example, 2,5-diacetoxybenzoic acid, 2-acetoxy-5-hydroxybenzoic acid, 2-hydroxy-5-propionyloxybenzoic acid, etc., and nicotinic acid derivatives include, for example, nicotinic acid amide, nicotinic acid benzyl, etc. However, examples of the vitamin E derivative include vitamin E nicotinate and vitamin E linoleate, and examples of the α-hydroxy acid include lactic acid, malic acid, succinic acid, citric acid, and α-hydroxyoctanoic acid.
又、本発明のアカザ科アッケシソウ属植物抽出物の有効性、特長を損なわない限り、他の肌荒れ改善剤や皮膚老化防止剤、抗酸化剤さらには抗炎症剤を組み合わせ化粧料に配合することは何ら差し支えない。 In addition, as long as the effectiveness and features of the plant extract of the genus Rhizoaceae of the present invention are not impaired, other skin roughness improving agents, skin anti-aging agents, antioxidants and further anti-inflammatory agents may be combined in cosmetics. There is no problem.
かかるものとしては、例えば肌荒れ改善剤や皮膚老化防止剤として、動物又は魚由来のコラーゲン及びその誘導体、エラスチン及びその誘導体、植物由来のコラーゲン様物質及びエラスチン様物質、ニコチン酸及びその誘導体、グリチルリチン酸及びその誘導体(ジカリウム塩等)、t−シクロアミノ酸誘導体、ビタミンA及びその誘導体、ビタミンE及びその誘導体、アラントイン、α−ヒドロキシ酸類、ジイソプロピルアミンジクロロアセテート、γ−アミノ−β−ヒドロキシ酪酸、ゲンチアナエキス、甘草エキス、ハトムギエキス、カミツレエキス、ニンジンエキス、アロエエキスなどの生薬抽出エキス、米抽出物加水分解物、米糠抽出物加水分解物、米醗酵エキス、ミツイシコンブ抽出物、アナアオサ抽出物、アマモ等の海草の抽出物、ソウハクヒエキス、ジュアゼイロ(Rhamnaceae zizyphus joazeiro)抽出物等がある。 Examples of such substances include skin roughness improving agents and skin antiaging agents, such as collagen derived from animals or fish and derivatives thereof, elastin and derivatives thereof, collagen-like substances derived from plants and elastin-like substances, nicotinic acid and derivatives thereof, glycyrrhizic acid And derivatives thereof (dipotassium salts, etc.), t-cycloamino acid derivatives, vitamin A and derivatives thereof, vitamin E and derivatives thereof, allantoin, α-hydroxy acids, diisopropylamine dichloroacetate, γ-amino-β-hydroxybutyric acid, gentian extract , Licorice extract, pearl barley extract, chamomile extract, carrot extract, aloe extract and other herbal extracts, rice extract hydrolyzate, rice bran extract hydrolysate, rice fermented extract, beetroot extract, anaaosa extract, amamo, etc. Seaweed extract Souhakuhiekisu, Juazeiro (Rhamnaceae zizyphus joazeiro) there is an extract or the like.
抗酸化剤としては、例えばブチルヒドロキシアニソール、ブチルヒドロキシトルエン、没食子酸プロピル、ビタミンE及びその誘導体、ビャッキュウ抽出物、イネ抽出物等がある。 Antioxidants include, for example, butylhydroxyanisole, butylhydroxytoluene, propyl gallate, vitamin E and its derivatives, beech extract, rice extract and the like.
抗炎症剤としては、例えばグリチルリチン酸、ゲンチアナ抽出物、カミツレ抽出物、オウゴン抽出物、アロエ抽出物等が挙げられる Examples of the anti-inflammatory agent include glycyrrhizic acid, gentian extract, chamomile extract, hornon extract, aloe extract and the like.
次に、実施例、処方例(化粧料の実施例)及び試験例を挙げて本発明をさらに具体的に説明するが、本発明はそれらに限定されるものではない。なお、以下に於いて、部はすべて重量部を、又%はすべて重量%を意味する。 Next, the present invention will be described more specifically with reference to examples, formulation examples (cosmetic examples), and test examples, but the present invention is not limited thereto. In the following, all parts are parts by weight, and all% are% by weight.
実施例1.皮膚バリア機能回復・抗酸化・抗炎症剤の調製(1)
アッケシソウ(Salicornia herbacea)の全草の乾燥細切物20gに精製水200gを加え、40℃で1時間抽出した。得られた抽出液をろ過して、褐色透明の抽出物溶液(固形分含量:1.9%)150gを得た。
Example 1. Preparation of skin barrier function recovery , antioxidant and anti-inflammatory agents (1)
200 g of purified water was added to 20 g of dried shredded whole plant of Salicornia herbacea and extracted at 40 ° C. for 1 hour. The obtained extract was filtered to obtain 150 g of a brown transparent extract solution (solid content: 1.9%).
実施例2.皮膚バリア機能回復・抗酸化・抗炎症剤の調製(2)
アッケシソウ(Salicornia herbacea)の茎の乾燥細切物20gに精製水200gを加え、40℃で3時間抽出した。得られた抽出液をろ過して、褐色透明の抽出物溶液(固形分含量:2.0%)150gを得た。
Example 2 Preparation of skin barrier function recovery , antioxidant and anti-inflammatory agents (2)
200 g of purified water was added to 20 g of dried chopped stalks of Salicornia herbacea and extracted at 40 ° C. for 3 hours. The obtained extract was filtered to obtain 150 g of a brown transparent extract solution (solid content: 2.0%).
実施例3.皮膚バリア機能回復・抗酸化・抗炎症剤の調製(3)
アッケシソウ(Salicornia herbacea)の全草の乾燥細切物20gに50%1,3−ブチレングリコール水溶液200gを加え、40℃で5時間抽出した。得られた抽出液をろ過して、淡褐色透明の抽出物溶液(固形分含量:1.8%)160gを得た。
Example 3 Preparation of skin barrier function recovery , antioxidant and anti-inflammatory agents (3)
200 g of a 50% 1,3-butylene glycol aqueous solution was added to 20 g of a dry cut of whole plant of Salicornia herbacea and extracted at 40 ° C. for 5 hours. The obtained extract was filtered to obtain 160 g of a light brown transparent extract solution (solid content: 1.8%).
実施例4.皮膚バリア機能回復・抗酸化・抗炎症剤の調製(4)
アッケシソウ(Salicornia herbacea)の全草の乾燥細切物20gに20%エタノール水溶液200gを加え、40℃で5時間抽出した。得られた抽出液をろ過して、淡褐色透明の抽出物溶液(固形分含量:1.8%)160gを得た。
Example 4 Preparation of skin barrier function recovery , antioxidant and anti-inflammatory agents (4)
200 g of a 20% ethanol aqueous solution was added to 20 g of dried shredded whole plant of Salicornia herbacea and extracted at 40 ° C. for 5 hours. The obtained extract was filtered to obtain 160 g of a light brown transparent extract solution (solid content: 1.8%).
実施例5.皮膚バリア機能回復・抗酸化・抗炎症剤の調製(5)
実施例1と同様にして得られた抽出物溶液100mlを10mlに濃縮した後凍結乾燥し、抽出物粉末1.8gを得た。
Example 5 FIG. Preparation of skin barrier function recovery , antioxidant and anti-inflammatory agents (5)
100 ml of the extract solution obtained in the same manner as in Example 1 was concentrated to 10 ml and freeze-dried to obtain 1.8 g of extract powder.
実施例6.皮膚バリア機能回復・抗酸化・抗炎症剤の調製(6)
実施例1に於いて、アッケシソウ(Salicornia herbacea)の全草に代えてサリコルニア ビゲロウィイ(Salicornia bigelovii)の全草を用いるほかは実施例1と同様にして、淡褐色透明の抽出物溶液(固形分含量:1.5%)130gを得た。
Example 6 Preparation of skin barrier function recovery , antioxidant and anti-inflammatory agents (6)
In Example 1, a light brown transparent extract solution (solid content) was obtained in the same manner as in Example 1 except that salicornia bigelovii whole plant was used instead of whole plant of Salicornia herbacea. : 1.5%) 130 g was obtained.
処方例1.クリーム
[A成分] 部
流動パラフィン 5.0
ヘキサラン (注1) 4.0
パラフィン 5.0
グリセリルモノステアレート 2.0
ポリオキシエチレン(20)ソルビタンモノステアレート 6.0
ブチルパラベン 0.1
(注1)株式会社テクノーブル製 トリオクタン酸グリセリル
[B成分]
実施例1の抽出物溶液 20.0
グリセリン 5.0
カルボキシメチルモノステアレート 0.1
モイストン・C (注2) 1.0
精製水 全量が100部となる量
(注2)株式会社テクノーブル製 NMF成分
[C成分]
香料 適量
上記のA成分とB成分をそれぞれ80℃以上に加熱した後、攪拌混合した。これを50℃まで冷却した後、C成分を加えてさらに攪拌混合してクリームを得た。
Formulation Example 1 Cream [Component A] Liquid paraffin 5.0
Hexalan (Note 1) 4.0
Paraffin 5.0
Glyceryl monostearate 2.0
Polyoxyethylene (20) sorbitan monostearate 6.0
Butylparaben 0.1
(Note 1) Technoble Co., Ltd. glyceryl trioctanoate
[B component]
Extract solution of Example 1 20.0
Glycerin 5.0
Carboxymethyl monostearate 0.1
Moiston C (Note 2) 1.0
Amount of purified water totaling 100 parts (Note 2) NMF component manufactured by Technoble Co., Ltd.
[C component]
Perfume
The components A and B were each heated to 80 ° C. or higher and then mixed by stirring. After this was cooled to 50 ° C., component C was added and further stirred and mixed to obtain a cream.
処方例2.クリーム
処方例1のB成分中実施例1の抽出物溶液に代えて実施例2の抽出物溶液を用いるほかは処方例1と同様にしてクリームを得た。
Formulation Example 2 Cream A cream was obtained in the same manner as in Formulation Example 1 except that the extract solution of Example 2 was used instead of the extract solution of Example 1 in Component B of Formulation Example 1.
処方例3.乳液
[A成分] 部
流動パラフィン 6.0
ヘキサラン 4.0
ホホバ油 1.0
ポリオキシエチレン(20)ソルビタンモノステアレート 2.0
大豆レシチン 1.5
メチルパラベン 0.15
エチルパラベン 0.03
[B成分]
実施例1の抽出物溶液 20.0
グリセリン 3.0
1、3−ブチレングリコール 2.0
カルボキシメチルセルロース 0.3
ヒアルロン酸ナトリウム 0.01
精製水 全量が100部となる量
[C成分]
香料 適量
上記のA成分とB成分をそれぞれ80℃以上に加熱した後、攪拌混合した。こ
れを50℃まで冷却した後、C成分を加えてさらに攪拌混合して乳液を得た。
Formulation Example 3 Emulsion [component A] part liquid paraffin 6.0
Hexalan 4.0
Jojoba oil 1.0
Polyoxyethylene (20) sorbitan monostearate 2.0
Soy lecithin 1.5
Methylparaben 0.15
Ethylparaben 0.03
[B component]
Extract solution of Example 1 20.0
Glycerin 3.0
1,3-butylene glycol 2.0
Carboxymethylcellulose 0.3
Sodium hyaluronate 0.01
Amount of purified water totaling 100 parts
[C component]
Perfume
The components A and B were each heated to 80 ° C. or higher and then mixed by stirring. After cooling this to 50 ° C., component C was added and further stirred and mixed to obtain an emulsion.
処方例4.ローション
[成分] 部
実施例3の抽出物溶液 30.0
エタノール 10.0
グリセリン 3.0
1、3−ブチレングリコール 2.0
メチルパラベン 0.2
クエン酸 0.1
クエン酸ナトリウム 0.3
カルボキシビニルポリマー 0.1
香料 適量
水酸化カリウム 適量
精製水 全量が100部となる量
上記の成分を混合してローションを得た。
Formulation Example 4 Lotion [component] part Extract solution of Example 3 30.0
Ethanol 10.0
Glycerin 3.0
1,3-butylene glycol 2.0
Methylparaben 0.2
Citric acid 0.1
Sodium citrate 0.3
Carboxyvinyl polymer 0.1
Perfume
Potassium hydroxide appropriate amount Purified water Amount that makes 100 parts in total
The above ingredients were mixed to obtain a lotion.
処方例5.化粧水
[A成分] 部
オリーブ油 1.0
ポリオキシエチレン(5.5)セチルアルコール 5.0
ブチルパラベン 0.1
[B成分]
実施例4の抽出物溶液 30.0
エタノール 5.0
グリセリン 5.0
1,3−ブチレングリコール 5.0
メチルパラベン 0.1
水酸化カリウム 適量
精製水 全量が100部となる量
[C成分]
香料 適量
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して化粧水を得た。
Formulation Example 5 Lotion [component A] part olive oil 1.0
Polyoxyethylene (5.5) cetyl alcohol 5.0
Butylparaben 0.1
[B component]
Extract solution of Example 4 30.0
Ethanol 5.0
Glycerin 5.0
1,3-butylene glycol 5.0
Methylparaben 0.1
Potassium hydroxide appropriate amount Purified water Amount that makes 100 parts in total
[C component]
Perfume
After each component A and component B was heated to 80 ° C. or higher, the component B was added to the component A and stirred, and further homogenized with Hiscotron (5000 rpm) for 2 minutes.
After cooling this to 50 degreeC, C component was added and stirred and mixed, and also it cooled to 30 degrees C or less, and the lotion was obtained.
処方例6.乳液
処方例3のB成分中、実施例1の抽出物溶液に代えて実施例2の抽出物溶液を用いるほかは処方例3と同様にして乳液を得た。
Formulation Example 6 Emulsion An emulsion was obtained in the same manner as in Formulation Example 3 except that the extract solution of Example 2 was used instead of the extract solution of Example 1 in the component B of Formulation Example 3.
処方例7.乳液
処方例3のB成分中、実施例1の抽出物溶液に代えて実施例3の抽出物溶液を用いるほかは処方例3と同様にして乳液を得た。
Formulation Example 7 Emulsion An emulsion was obtained in the same manner as in Formulation Example 3 except that the extract solution of Example 3 was used instead of the extract solution of Example 1 in the component B of Formulation Example 3.
処方例8.乳液
処方例3のB成分中、実施例1の抽出物溶液に代えて実施例6の抽出物溶液を用いるほかは処方例3と同様にして乳液を得た。
Formulation Example 8 Emulsion An emulsion was obtained in the same manner as in Formulation Example 3 except that the extract solution of Example 6 was used instead of the extract solution of Example 1 in Component B of Formulation Example 3.
処方例9.乳液
[A成分] 部
流動パラフィン 6.0
ヘキサラン 4.0
ホホバ油 1.0
ポリオキシエチレン(20)ソルビタンモノステアレート 2.0
大豆レシチン 1.5
メチルパラベン 0.15
エチルパラベン 0.03
[B成分]
実施例1の抽出物溶液 20.0
L−アスコルビン酸−2−グルコシド 2.0
水酸化カリウム 0.5
グリセリン 3.0
1、3−ブチレングリコール 2.0
カルボキシメチルセルロース 0.3
ヒアルロン酸ナトリウム 0.01
精製水 全量が100部となる量
[C成分]
香料 適量
上記のA成分とB成分をそれぞれ80℃以上に加熱した後、攪拌混合した。これを50℃まで冷却した後、C成分を加えてさらに攪拌混合して乳液を得た。
Formulation Example 9 Emulsion [component A] part liquid paraffin 6.0
Hexalan 4.0
Jojoba oil 1.0
Polyoxyethylene (20) sorbitan monostearate 2.0
Soy lecithin 1.5
Methylparaben 0.15
Ethylparaben 0.03
[B component]
Extract solution of Example 1 20.0
L-ascorbic acid-2-glucoside 2.0
Potassium hydroxide 0.5
Glycerin 3.0
1,3-butylene glycol 2.0
Carboxymethylcellulose 0.3
Sodium hyaluronate 0.01
Amount of purified water totaling 100 parts
[C component]
Perfume
The components A and B were each heated to 80 ° C. or higher and then mixed by stirring. After cooling this to 50 ° C., component C was added and further stirred and mixed to obtain an emulsion.
実施例10.乳液
処方例9のB成分中、L−アスコルビン酸−2−グルコシド2.0部及び水酸化カリウム0.5部に代えてL−アスコルビン酸−2−リン酸エステルマグネシウム2.0部を用いるほかは処方例9と同様にして乳液を得た。
Example 10 Emulsion In addition to using 2.0 parts of L-ascorbic acid-2-phosphate magnesium in place of 2.0 parts of L-ascorbic acid-2-glucoside and 0.5 parts of potassium hydroxide in the component B of Formulation Example 9. Gave a milky lotion in the same manner as in Formulation Example 9.
処方例11.乳液
処方例9のB成分中、L−アスコルビン酸−2−グルコシド2.0部及び水酸化カリウム0.5部に代えてL−アスコルビン酸−2−リン酸エステルナトリウム2.0部を用いるほかは処方例9と同様にして乳液を得た。
Formulation Example 11 Emulsion In addition to using 2.0 parts of L-ascorbic acid-2-phosphate and 2.0 parts of L-ascorbic acid-2-phosphate in place of 2.0 parts of L-ascorbic acid-2-glucoside and 0.5 parts of potassium hydroxide in component B of formulation example 9 Gave a milky lotion in the same manner as in Formulation Example 9.
処方例12.乳液
処方例9のB成分中、L−アスコルビン酸−2−グルコシド2.0部及び水酸化カリウム0.5部に代えてアルブチン2.0部を用いるほかは処方例9と同様にして乳液を得た。
Formulation Example 12. Emulsion In the component B of Formulation Example 9, the emulsion was prepared in the same manner as Formulation Example 9, except that 2.0 parts of arbutin was used instead of 2.0 parts of L-ascorbic acid-2-glucoside and 0.5 part of potassium hydroxide. Obtained.
処方例13.乳液
処方例9のB成分中、L−アスコルビン酸−2−グルコシド2.0部及び水酸化カリウム0.5部に代えて米糠抽出物加水分解物(株式会社テクノーブル製、商品名「グレイスノウ*雪*HP」、固形分濃度3.5%)5.0部を用いるほかは処方例9と同様にして乳液を得た。
Formulation Example 13 Emulsion In the component B of Formulation Example 9, instead of 2.0 parts of L-ascorbic acid-2-glucoside and 0.5 part of potassium hydroxide, a rice bran extract hydrolyzate (trade name “Grace Know” manufactured by Technoble Co., Ltd.) An emulsion was obtained in the same manner as in Formulation Example 9, except that 5.0 parts of * Snow * HP ", solid concentration 3.5%) were used.
処方例14.乳液
処方例9のB成分中、L−アスコルビン酸−2−グルコシド2.0部及び水酸化カリウム0.5部に代えて白芥子抽出物(株式会社テクノーブル製、商品名「シナブランカ−WH」、固形分濃度1.0%)5.0部を用いるほかは処方例9と同様にして乳液を得た。
Formulation Example 14. Emulsion White coconut extract (trade name “Sinablanca-WH” manufactured by Technoble Co., Ltd.) instead of 2.0 parts of L-ascorbic acid-2-glucoside and 0.5 part of potassium hydroxide in the B component of Formulation Example 9. The emulsion was obtained in the same manner as in Formulation Example 9, except that 5.0 parts of a solid content concentration of 1.0% was used.
処方例15.乳液
処方例9のB成分中、L−アスコルビン酸−2−グルコシド2.0部及び水酸化カリウム0.5部に代えてγ−アミノ−β−ヒドロキシ酪酸1.0部を用いるほかは処方例9と同様にして乳液を得た。
Formulation Example 15. Emulsion Formulation Example 9 in the component B except that 2.0 parts of L-ascorbic acid-2-glucoside and 0.5 part of potassium hydroxide are used instead of 1.0 part of γ-amino-β-hydroxybutyric acid In the same manner as in No. 9, an emulsion was obtained.
処方例16.プレストパウダー
[A成分] 部
ベンガラ 0.5
黄酸化鉄 1.5
黒酸化鉄 0.1
酸化チタン 10.0
ナイロンパウダー 4.0
セリサイト 全量が100部となる量
マイカ 23.0
タルク 25.0
実施例5の抽出物粉末 0.5
[B成分]
スクワラン 1.0
メチルポリシロキサン 4.0
プロピルパラベン 0.1
デヒドロ酢酸 0.1
流動パラフィン 2.0
香料 適量
上記のA成分とB成分をそれぞれ混合攪拌し混合した後、200メッシュのタイラーメッシュの篩にかけ、得られた混合粉末を金型に打型してプレストパウダーを得た。
Formulation Example 16. Pressed powder [A component] Part Bengala 0.5
Yellow iron oxide 1.5
Black iron oxide 0.1
Titanium oxide 10.0
Nylon powder 4.0
Amount that makes 100 parts of sericite Mica 23.0
Talc 25.0
Extract powder of Example 5 0.5
[B component]
Squalane 1.0
Methylpolysiloxane 4.0
Propylparaben 0.1
Dehydroacetic acid 0.1
Liquid paraffin 2.0
Perfume
The above A component and B component were mixed and agitated, mixed, then passed through a 200 mesh Tyler mesh sieve, and the resulting mixed powder was cast into a mold to obtain a pressed powder.
処方例17.リクイドファンデーション
[A成分] 部
ステアリン酸 2.4
モノステアリン酸プロピレングリコール 2.0
セトステアリルアルコール 0.2
液状ラノリン 2.0
流動パラフィン 3.0
ミリスチン酸イソプロピル 8.5
プロピルパラベン 0.05
[B成分]
実施例2の抽出物溶液 5.0
カルボキシメチルセルロースナトリウム 0.2
ベントナイト 0.5
プロピレングリコール 4.0
トリエタノールアミン 1.1
メチルパラベン 0.1
精製水 全量が100部となる量
[C成分]
酸化チタン 8.0
タルク 4.0
着色顔料 適量
上記のA成分とB成分をそれぞれ加温した後混合攪拌した。これを再加温し、上記のC成分を添加して型に流し込み、室温になるまで攪拌してリキッドファンデーションを得た。
Formulation Example 17. Liquid foundation [component A] part Stearic acid 2.4
Propylene glycol monostearate 2.0
Cetostearyl alcohol 0.2
Liquid lanolin 2.0
Liquid paraffin 3.0
Isopropyl myristate 8.5
Propylparaben 0.05
[B component]
Extract solution of Example 2 5.0
Sodium carboxymethylcellulose 0.2
Bentonite 0.5
Propylene glycol 4.0
Triethanolamine 1.1
Methylparaben 0.1
Purified water Amount that makes the total amount 100 parts [C component]
Titanium oxide 8.0
Talc 4.0
Coloring pigment appropriate amount The components A and B were heated and mixed and stirred. This was reheated, the above C component was added, poured into a mold, and stirred until it reached room temperature to obtain a liquid foundation.
処方例18.クリームファンデーション
[A成分] 部
ステアリン酸 5.0
セタノール 2.0
モノステアリン酸グリセリル 3.0
流動パラフィン 5.0
スクワラン 3.0
ミリスチン酸イソプロピル 8.0
ポリオキシエチレン(20)モノステアリン酸グリセリル 2.0
プロピルパラベン 0.1
[B成分]
実施例3の抽出物溶液 10.0
ソルビトール 3.0
1,3−ブチレングリコール 5.0
トリエタノールアミン 1.5
メチルパラベン 0.1
精製水 全量が100部となる量
[C成分]
酸化チタン 8.0
タルク 2.0
カオリン 5.0
ベントナイト 1.0
着色顔料 適 量
[D成分]
香料 0.3
C成分を混合し、粉砕機で粉砕した。B成分を混合し、これに粉砕したC成分を加え、コロイドミルで均一分散させた。A成分及び均一分散させたB、C成分をそれぞれ80℃に加温後、B、C成分にA成分を攪拌しながら加え、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。これを50℃まで冷却した後、D成分を加えて攪拌混合し、さらに攪拌しながら30℃以下まで冷却してクリームファンデーションを得た。
Formulation Example 18. Cream foundation [component A] part Stearic acid 5.0
Cetanol 2.0
Glyceryl monostearate 3.0
Liquid paraffin 5.0
Squalane 3.0
Isopropyl myristate 8.0
Polyoxyethylene (20) glyceryl monostearate 2.0
Propylparaben 0.1
[B component]
Extract solution of Example 3 10.0
Sorbitol 3.0
1,3-butylene glycol 5.0
Triethanolamine 1.5
Methylparaben 0.1
Purified water Amount of 100 parts [component C]
Titanium oxide 8.0
Talc 2.0
Kaolin 5.0
Bentonite 1.0
Coloring pigment appropriate amount [component D]
Fragrance 0.3
Component C was mixed and pulverized with a pulverizer. The component B was mixed, and the pulverized component C was added thereto and uniformly dispersed in a colloid mill. The components A and B and C dispersed uniformly were each heated to 80 ° C., and then the components A were added to the components B and C while stirring, and further homogenized with Hiscotron (5000 rpm) for 2 minutes. After cooling this to 50 degreeC, D component was added and stirred and mixed, and also it cooled to 30 degrees C or less, stirring, and obtained the cream foundation.
処方例19.ボディシャンプー
[A成分] 部
N−ラウロイルメチルアラニンナトリウム 25.0
ヤシ油脂肪酸カリウム液(40%) 26.0
ヤシ油脂肪酸ジエタノールアミド 3.0
メチルパラベン 0.1
[B成分]
実施例3の抽出物溶液 10.0
1,3−ブチレングリコール 2.0
精製水 全量が100部となる量
A成分及びB成分をそれぞれ80℃に加温して均一に溶解した後、A成分にB成分を加え、攪拌を続けて室温まで冷却してボディシャンプーを得た。
Formulation Example 19. Body shampoo [component A] part N-lauroylmethylalanine sodium 25.0
Palm oil fatty acid potassium liquid (40%) 26.0
Palm oil fatty acid diethanolamide 3.0
Methylparaben 0.1
[B component]
Extract solution of Example 3 10.0
1,3-butylene glycol 2.0
Purified water Amount to be 100 parts A component and B component are each heated to 80 ° C and dissolved uniformly, then B component is added to A component and stirring is continued to cool to room temperature to obtain a body shampoo It was.
処方例20.石けん
[A成分] 部
硬化ヒマシ油 26.0
ヤシ油 10.0
オリーブ油 4.0
[B成分]
水酸化ナトリウム 6.0
砂糖 10.0
グリセリン 5.0
実施例5の抽出物粉末 0.5
精製水 全量が100部となる量
[C成分]
エタノール 20.0
香料 適量
A成分及びB成分をそれぞれ80℃に加温して均一に溶解した後、A成分にB成分を加えてケン化した。これを攪拌しながら50℃まで冷却し、C成分を加えた。これを型に流し込み冷却した後、室温下で数日間乾燥させ、充分に乾燥したものを型から取りだして石けんを得た。
Formulation Example 20. Soap [component A] part hardened castor oil 26.0
Coconut oil 10.0
Olive oil 4.0
[B component]
Sodium hydroxide 6.0
Sugar 10.0
Glycerin 5.0
Extract powder of Example 5 0.5
Purified water Amount of 100 parts [component C]
Ethanol 20.0
Perfume Appropriate A component and B component were each heated to 80 ° C. and dissolved uniformly, and then B component was added to A component to saponify. This was cooled to 50 ° C. with stirring, and component C was added. This was poured into a mold and cooled, and then dried at room temperature for several days. A sufficiently dried product was taken out from the mold to obtain soap.
試験例1.皮膚バリア機能回復作用
本発明のアッケシソウ属植物抽出物を皮膚に適用した時の経皮水分蒸散量(TEWL)の変化を測定することにより、該抽出物の皮膚バリア機能回復作用を調べた。
[試料]
1.防腐水(防腐剤として、1,3-ブチレングリコール、メチルパラベン及び エチルパラベンを、それぞれ5%、0.15%及び0.03%含む)(対照)
2.実施例1の抽出液を20%含む防腐水(防腐剤組成は対照と同じ)(本発明試料)
Test Example 1 Skin Barrier Function Recovery Action The skin barrier function recovery action of the extract was examined by measuring changes in transdermal water transpiration (TEWL) when the extract of the plant of the genus Genus of the present invention was applied to the skin.
[sample]
1. Preservative water (contains 5%, 0.15% and 0.03% of 1,3-butylene glycol, methylparaben and ethylparaben as preservatives, respectively) (control)
2. Preservative water containing 20% of the extract of Example 1 (preservative composition is the same as the control) (sample of the present invention)
[試験方法]
年齢20〜50歳の成人男子10名を被験者とし、各被験者の前腕内側部に被験部位を2ヶ所設け、該部位をSDSで処理して人為的に荒れ肌を生ぜしめた。
この被験部位の一方に対照の防腐水を又他方に本発明試料を、それぞれ1日2回(朝、夕)0.1mlずつ3日間塗布し、塗布開始1日後、2日後及び3日後の朝の試料塗布前に、被験部位のTEWLをバポメーター(キーストン社製、型式SWL2001N)を用いて測定した。測定は各被験部位毎に3回繰り返して行い、その平均値をとった。
皮膚バリア機能の回復の度合(バリア機能回復率%)は、TEWLが最も高い値を示した塗布1日後の値を100とし、これに対する塗布2日後及び3日後のTEWLの相対値から次式により求めた。
バリア機能回復率(%)=100−2日又は3日後のTEWL(相対値)
[Test method]
Ten adult males aged 20 to 50 years were used as subjects, and two test sites were provided on the inner forearm of each subject, and the sites were treated with SDS to artificially cause rough skin.
The control antiseptic water is applied to one of the test sites, and the sample of the present invention is applied to the other side twice a day (morning and evening) for 3 days, each day for 3 days. Before the sample application, the TEWL of the test site was measured using a barometer (manufactured by Keystone, model SWL2001N). The measurement was repeated three times for each test site, and the average value was taken.
The degree of recovery of the skin barrier function (barrier function recovery rate%) is defined as 100 from the value after 1 day of application when TEWL showed the highest value, and the relative value of TEWL after 2 days and 3 days after application according to the following formula: Asked.
Barrier function recovery rate (%) = TEWL (relative value) after 100-2 days or 3 days
[結果]
結果を図1に示す。図1に於いて、バリア機能回復率(%)は被験者10名の平均値である。
図1の結果から、本発明のアッケシソウ属植物抽出物がすぐれたバリア機能回復作用を有することが明らかである。
[result]
The results are shown in FIG. In FIG. 1, the barrier function recovery rate (%) is an average value of 10 subjects.
From the result of FIG. 1, it is clear that the extract of the plant of the genus Rhododendron according to the present invention has an excellent barrier function restoring action.
試験例2.抗酸化作用 [DPPH(1,1-ジフェニル-2-ピクリルヒドラジル)ラジカルスカベンジ試験])
[試料]
1.実施例1の抽出物溶液(本発明試料)
2.トロロックスの50%エタノール溶液(ポジティブコントロール)
Test Example 2 Antioxidant [DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenge test])
[sample]
1. Extract solution of Example 1 (invention sample)
2.
[試験方法]
96穴マイクロプレートに本発明試料又はポジティブコントロールをそれぞれ50μl添加し、これに表1の組成からなるDPPH添加液もしくは対照液150μlを加え、37℃で20分間インキュベートした後、550nmで比色定量を行った。
DPPH添加液を加えた反応液の吸光度から対照液を加えた反応液の吸光度を差し引いた値をDPPHラジカル量とした。
[Test method]
Add 50 μl each of the sample of the present invention or positive control to a 96-well microplate, add 150 μl of DPPH additive solution or control solution having the composition shown in Table 1 and incubate at 37 ° C. for 20 minutes, and then perform colorimetric determination at 550 nm. went.
The DPPH radical amount was obtained by subtracting the absorbance of the reaction solution added with the control solution from the absorbance of the reaction solution added with the DPPH additive solution.
[結果]
結果を図2に示す。
図2の結果から、本発明のアッケシソウ属植物抽出物がすぐれたラジカルスカベンジ能を有し、抗酸化剤として有用であること、又従って、該抽出物を配合してなる本発明の化粧料によれば、皮膚に対する酸化ダメージが軽減乃至抑止されて、表皮及び真皮の細胞の機能は正常かつ健全な状態に保持され、これにより皮膚の老化が防止或いは改善されることが判る。
[result]
The results are shown in FIG.
From the results shown in FIG. 2, the extract of the plant belonging to the genus Rhododendron has excellent radical scavenging ability and is useful as an antioxidant, and therefore, the cosmetic of the present invention comprising the extract is blended. According to this, it can be seen that oxidative damage to the skin is reduced or suppressed, and the functions of cells of the epidermis and dermis are maintained in a normal and healthy state, thereby preventing or improving skin aging.
試験例3.シクロオキシゲナーゼ活性の抑制に基づく抗炎症作用
[試料]
1.実施例3の抽出物溶液の10%水溶液(本発明試料)
2.精製水(対照)
[試験方法]
20mMトリプトファン/0.2MTris-HCl緩衝液(pH8.0)2.52mlに40mMヘモグロビン/0.2MTris-HCL緩衝液(pH8.0)0.03ml及び試料0.15mlを混和した。これを37℃に加温した後、2mMアラキドン酸/0.2mMTris-HCL緩衝液(pH8.0)0.1ml及び250unit/mlシクロオキシゲナーゼ0.2mlを混和し、密閉状態で攪拌しながら10分間アラキドン酸を基質とするシクロオキシゲナーゼ酵素反応を行った。
反応経過中、生物酸素モニター(YSI MODEL 5300)を用いて規定時間毎の溶存酸素濃度を計測し、反応直前の溶存酸素濃度を100%として経時的な酸素消費率を算出した。
各時間に於ける酸素消費率をχ%としたとき、試料溶液3ml中の酸素消費量は次式によって求められる。
試料溶液中の酸素消費量(μl)=χ/100×5.02×3
Test Example 3 Anti-inflammatory action based on suppression of cyclooxygenase activity [Sample]
1. 10% aqueous solution of the extract solution of Example 3 (sample of the present invention)
2. Purified water (control)
[Test method]
To 2.52 ml of 20 mM tryptophan / 0.2 MTris-HCl buffer (pH 8.0), 0.03 ml of 40 mM hemoglobin / 0.2 MTris-HCL buffer (pH 8.0) and 0.15 ml of a sample were mixed. After warming to 37 ° C, mix 0.1 ml of 2 mM arachidonic acid / 0.2 mM Tris-HCL buffer (pH 8.0) and 0.2 ml of 250 unit / ml cyclooxygenase, and use arachidonic acid as a substrate for 10 minutes while stirring in a sealed state. A cyclooxygenase enzyme reaction was carried out.
During the course of the reaction, the dissolved oxygen concentration was measured every specified time using a biological oxygen monitor (YSI MODEL 5300), and the oxygen consumption rate over time was calculated with the dissolved oxygen concentration immediately before the reaction as 100%.
When the oxygen consumption rate at each time is χ%, the oxygen consumption amount in 3 ml of the sample solution is obtained by the following equation.
Oxygen consumption in sample solution (μl) = χ / 100 × 5.02 × 3
[結果]
経時的な酸素消費量の変化を図3に示す。
図3の結果から明らかな通り、本発明のアッケシソウ属植物抽出物は顕著なシクロオキシゲナーゼ活性抑制効果を有しており、抗炎症剤として有用である。
又、このアッケシソウ属植物抽出物を配合してなる本発明の化粧料は、該抽出物の有する抗炎症作用により皮膚の老化防止にすぐれた効果を示す。
[result]
The change in oxygen consumption over time is shown in FIG.
As is apparent from the results of FIG. 3, the plant extract of the genus Hydrangea of the present invention has a remarkable cyclooxygenase activity inhibitory effect and is useful as an anti-inflammatory agent.
In addition, the cosmetic of the present invention, which is obtained by blending this genus plant extract, exhibits an excellent effect in preventing skin aging due to the anti-inflammatory action of the extract.
試験例4.皮膚刺激性
[試料]
(1)実施例1で得られた抽出物溶液(本発明試料)
(2)精製水(対照)
Test Example 4 Skin irritation
[sample]
(1) Extract solution obtained in Example 1 (sample of the present invention)
(2) Purified water (control)
[試験方法]
年齢20〜50歳の成人男子5名を被験者とし、各々の上腕部内側をエタノールで拭って皮脂を除去し、該部位に、フィンチャンバーのアルミ板に各試料をそれぞれ0.2ml宛塗布したものを貼付した。24時間後にフィンチャンバーを除去し、皮膚刺激の程度をつぎに述べる方法並びに基準により判定した。
[判定]
パッチ除去後1時間後、24時間後及び48時間後に、貼付部位の紅斑及び浮腫の状況を、以下の「ドレイズ法による皮膚刺激性判定基準」に基づき目視判定し、被験者5名の平均値を求めた。
(紅斑)
スコア 皮膚の状態
0 : 紅斑なし
1 : 極く軽度の紅斑
2 : 明らかな紅斑
3 : 中程度から強い紅斑
4 : 深紅色の強い紅斑に軽い痂皮形成
(浮腫)
スコア 皮膚の状態
0 : 浮腫なし
1 : 極く軽度の浮腫
2 : 明らかな浮腫(周囲と明らかに区別可能)
3 : 中程度の浮腫(1mm以上の盛り上がり)
4 : 強い浮腫(さらに周囲にも広がり)
[Test method]
Five adult males aged 20 to 50 years old were subjects, and the inner side of each upper arm was wiped with ethanol to remove sebum, and 0.2 ml of each sample was applied to the aluminum plate of the fin chamber. Was affixed. After 24 hours, the fin chamber was removed, and the degree of skin irritation was determined by the method and criteria described below.
[Judgment]
After 1 hour, 24 hours and 48 hours after removing the patch, the state of erythema and edema at the applied site was visually determined based on the following “skin irritation criteria by dreze method”, and the average value of 5 subjects was calculated. Asked.
(Erythema)
Score skin condition 0: No erythema 1: Extremely mild erythema 2: Clear erythema 3: Moderate to strong erythema 4: Light crust formation in deep crimson erythema (edema)
Score skin condition 0: No edema 1: Extremely mild edema 2: Clear edema (distinguishable from surroundings)
3: Moderate edema (swelling of 1 mm or more)
4: Strong edema (further spread around)
[結果]
結果を表2に示す。
The results are shown in Table 2.
表2の結果から明らかな通り、アッケシソウ属植物の抽出物は皮膚に対する刺激が殆どなく、生体安全性に極めてすぐれている。 As is apparent from the results in Table 2, the extract of the plant belonging to the genus Hydrangea has almost no irritation to the skin and is extremely excellent in biological safety.
試験例4.パネルテスト(その1)
本発明のアッケシソウ属植物の抽出物を配合した化粧料について、パネルテストにより肌荒れに対する改善効果を調べた。
[試料]
(1)処方例1のクリーム (本発明例)
(2)処方例1に於いて、実施例1の抽出物溶液の代わりに精製水を用いて得られたクリーム(対照)
Test Example 4 Panel test (Part 1)
About the cosmetics which mix | blended the extract of the genus Hydrangea of this invention, the improvement effect with respect to rough skin was investigated by the panel test.
[sample]
(1) Cream of Formulation Example 1 (Invention Example)
(2) Cream obtained by using purified water instead of the extract solution of Example 1 in the formulation example 1 (control)
[試験方法]
無作為に抽出した年齢18〜50歳の女性20名を被験者とし、それぞれ左右の頬部に、本発明例又は対照のクリームを1日2回(朝、晩)、1ヵ月間塗布してもらった後、皮膚の乾燥及び落屑に対する改善効果を、以下の評価基準に基づいて評価した。
[Test method]
Twenty randomly selected women aged 18 to 50 years were used as subjects, and the inventive example or control cream was applied to the left and right cheeks twice a day (morning and evening) for one month. Then, the improvement effect with respect to skin drying and desquamation was evaluated based on the following evaluation criteria.
[評価基準]
A:明らかに改善された
B:かなり改善された
C:僅かに改善された
D:変わらない
E:かえって悪くなった
[Evaluation criteria]
A: Clearly improved B: Much improved C: Slightly improved D: No change E: On the contrary
[結果]
結果を表3に示す。なお、表3のA〜Eの各評価欄の数字は、被験者20名中当該評価を行った被験者の割合(%)を示す。
[result]
The results are shown in Table 3. In addition, the number of each evaluation column of AE of Table 3 shows the ratio (%) of the test subject who performed the said evaluation among 20 test subjects.
表3の結果から、本発明の化粧料が、肌荒れの特徴的な症状である皮膚の乾燥や落屑に対してすぐれた改善効果を有することが判る。 From the results in Table 3, it can be seen that the cosmetic of the present invention has an excellent improvement effect on skin dryness and desquamation, which are characteristic symptoms of rough skin.
試験例4.パネルテスト(その2))
本発明のアッケシソウ属植物の抽出物を配合した化粧料について、パネルテストにより皮膚の老化防止に対する効果を調べた。
[試料]
(1)処方例2のクリーム(本発明例)
(2)処方例2に於いて、実施例2の抽出物溶液の代わりに精製水を用いて得られたクリーム(対照)
Test Example 4 Panel test (Part 2))
About the cosmetics which mix | blended the extract of the genus Hydrangea of this invention, the effect with respect to skin aging prevention was investigated by the panel test.
[sample]
(1) Cream of Formulation Example 2 (Invention Example)
(2) Cream obtained by using purified water instead of the extract solution of Example 2 in the formulation example 2 (control)
[試験方法]
無作為に抽出した年齢18〜50歳の女性20名を被験者としてそれぞれ左右の頬部に、本発明例又は対照のクリームを1日2回(朝、晩)、3ヵ月間塗布してもらった後、小じわ及び肌のはり、艶に対する改善効果を、以下の評価基準に基づいて評価した。
[Test method]
Twenty randomly selected women aged 18 to 50 years were used as subjects, and the inventive example or control cream was applied to the left and right cheeks twice a day (morning and evening) for 3 months. Then, the improvement effect with respect to fine wrinkles, skin tension, and gloss was evaluated based on the following evaluation criteria.
[評価基準]
A:明らかに改善された
B:かなり改善された
C:僅かに改善された
D:変わらない
E:かえって悪くなった
[Evaluation criteria]
A: Clearly improved B: Much improved C: Slightly improved D: No change E: On the contrary
[結果]
結果を表4に示す。なお、表4のA〜Eの各評価欄の数字は、被験者20名中当該評価を行った被験者の割合(%)を示す。
[result]
The results are shown in Table 4. In addition, the number of each evaluation column of AE of Table 4 shows the ratio (%) of the test subject who performed the said evaluation among 20 test subjects.
表4の結果から、本発明のアッケシソウ属植物抽出物を配合した化粧料が、小ジワや肌のハリ、艶を顕著に改善し、皮膚の老化防止に有効であることが明らかである。 From the results of Table 4, it is clear that the cosmetics containing the plant extract of the present invention of the present invention remarkably improve fine wrinkles, skin firmness and gloss, and are effective in preventing skin aging.
A 対照
B 本発明試料
A control
B Sample of the present invention
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003385315A JP3987825B2 (en) | 2003-11-14 | 2003-11-14 | Cosmetics and cosmetic ingredients |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003385315A JP3987825B2 (en) | 2003-11-14 | 2003-11-14 | Cosmetics and cosmetic ingredients |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005145878A JP2005145878A (en) | 2005-06-09 |
JP3987825B2 true JP3987825B2 (en) | 2007-10-10 |
Family
ID=34693425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003385315A Expired - Fee Related JP3987825B2 (en) | 2003-11-14 | 2003-11-14 | Cosmetics and cosmetic ingredients |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3987825B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101022137B1 (en) | 2010-07-30 | 2011-03-17 | 정애리시 | The manufacturing method of salicornia herbacea oil |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2903308B1 (en) * | 2006-07-06 | 2011-07-29 | Clarins Lab | USE OF A COSMETIC COMPOSITION TO COMBAT THE EFFECTS OF ELECTROMAGNETIC WAVES ON THE SKIN |
KR101107833B1 (en) | 2009-06-23 | 2012-01-31 | 주식회사 바이오에프디엔씨 | Skin Composition for External Application Containing Salicornia herbacea and Preparing the Same |
KR101124971B1 (en) * | 2009-08-03 | 2012-03-27 | (주)더페이스샵 | Cosmetic composition containing Salicornia herbacea callus Extracts and Laminaria digitata Extracts for Improving Skin Wrinkle or enhancing skin Elasticity |
US8383167B2 (en) * | 2011-03-08 | 2013-02-26 | Elc Management, Llc | Method for cosmetically treating caspase-14 deficiency |
US20140205550A1 (en) * | 2013-01-23 | 2014-07-24 | Hugo A. Corstjens | Method for Cosmetically Treating Caspase-14 Deficiency |
US10765621B2 (en) | 2013-09-22 | 2020-09-08 | Symrise Ag | Extracts of halimione portulacoides and their application |
JP7376899B2 (en) | 2017-05-24 | 2023-11-09 | 共栄化学工業株式会社 | Skin external preparations |
-
2003
- 2003-11-14 JP JP2003385315A patent/JP3987825B2/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101022137B1 (en) | 2010-07-30 | 2011-03-17 | 정애리시 | The manufacturing method of salicornia herbacea oil |
Also Published As
Publication number | Publication date |
---|---|
JP2005145878A (en) | 2005-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5020475B2 (en) | Fibroblast activator and skin external preparation containing the same | |
JP6266857B2 (en) | Cosmetics | |
JP4960948B2 (en) | Method for producing plant extract and cosmetics | |
JP5698586B2 (en) | Cosmetics | |
JP2006290742A (en) | Antiaging cosmetic | |
JP5517119B2 (en) | Cosmetics | |
JP4495925B2 (en) | Collagen and elastin production promoter and anti-aging cosmetic containing the same | |
JP4755845B2 (en) | A cosmetic comprising a testosterone-5α-reductase inhibitor and a testosterone-5α-reductase inhibitor. | |
JP3987825B2 (en) | Cosmetics and cosmetic ingredients | |
JP4769153B2 (en) | Cosmetics | |
JP2014221754A (en) | Cosmetic | |
JP5900915B2 (en) | Whitening cosmetics | |
JP2006143670A (en) | Skin lotion | |
JP5812562B2 (en) | Cosmetics | |
JP6559948B2 (en) | Skin turnover improver | |
JP5177827B2 (en) | Topical skin preparation | |
JP2005145938A (en) | Active oxygen scavenger and cosmetic | |
JP6704628B2 (en) | Cosmetics | |
JP4573545B2 (en) | Cosmetics | |
JP2005126394A (en) | Superoxide dismutase activity enhancer and cosmetic containing the same | |
JP5057638B2 (en) | Topical skin preparation | |
JP2003238429A (en) | Fibroblast cell-activating agent and skin external agent containing the same | |
JP5571940B2 (en) | Topical skin preparation | |
JP4488789B2 (en) | Enzyme-treated decomposition product and cosmetics containing the same | |
JP4028837B2 (en) | Cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050802 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20060712 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060817 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061222 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070220 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070625 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070713 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 3987825 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100720 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100720 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130720 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |